Oakview Terrace in Freeman, SD

Oakview Terrace is a medicare and medicaid certified nursing home in Freeman, South Dakota. It is located in Hutchinson county at 510 E 8th St, Freeman, South Dakota 57029. You can reach out to the office of Oakview Terrace via phone at (605) 925-4000. This skilled nursing facility has 51 federally certified beds with average occupancy rate of 80.78%. Its legal business name is Freeman Regional Health Services and has the following ownership type - Non Profit - Corporation.

Oakview Terrace (Medicare CCN 435112) is certified by CMS (Centers for Medicare & Medicaid Services) and participates in both medicare and medicaid program. This means if you are part of medicare or medicaid program, you may consider this nursing facility for your medical needs. It was first certified by CMS in 1998 (26 years certified) and the last quality survey was conducted in March, 2019.

Contact Information

Oakview Terrace
510 E 8th St, Freeman, South Dakota 57029
(605) 925-4000


Nursing Home Profile

NameOakview Terrace
Location510 E 8th St, Freeman, South Dakota
Certified ByMedicare and Medicaid
No. of Certified Beds51
Occupancy Rate80.78%
Medicare ID (CCN)435112
Legal Business NameFreeman Regional Health Services
Ownership TypeNon Profit - Corporation

NPI Associated with this Nursing Home:

Nursing Homes may have multiple NPI numbers. We have found possible NPI number/s associated with Oakview Terrace from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1831206820
Organization NameFREEMAN REGIONAL HEALTH SERVICES
Address510 E 8th St, Freeman, SD 57029
Phone Number605-925-4000

News Archive

Preventing spread of infectious diseases is everyone's responsibility – and everyone's job

According to a report published today, we must all share responsibility for preventing the spread of diseases such as swine flu, SARS, avian influenza, diarrhoeal and skin diseases, and even the common cold.

Research leads to new potential treatment for Hereditary Hemorrhagic Telangiectasia

The work of researchers Francesc Viñals and Mariona Graupera at the Bellvitge Biomedical Research Institute - Catalan Institute of Oncology - University of Barcelona, together with Dr. Antoni Riera-Mestre, has led to a new potential treatment for Hereditary Hemorrhagic Telangiectasia or Rendu-Osler Syndrome, a rare disease that affects blood vessels and had no described treatment.

Medgen completes acquisition of Alternaturals

Medgen, Inc. today announced that it has completed the acquisition of Alternaturals, the operating subsidiary of Alternaturals, Inc., and a popular alternative healthcare and natural remedies company. The acquisition was made in an effort to increase the company's consumer reach and revenue base, and could be the most exciting event in several years, positioning the company to take some major steps forward.

Quark Pharmaceuticals commences dosing in clinical study of QPI-1007 for NAION

Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, announced today the dosing of the first patient in a Phase I study of the investigational neuroprotective agent, QPI-1007.

Read more Medical News

› Verified 4 days ago

Quality Ratings:

Nursing homes vary in the quality of care and services they provide to their residents. The below quality ratings for Oakview Terrace are calculated from three sources - health inspection results, staffing data, and quality measure data. This information gives you an indication of the care Oakview Terrace give to their patients.
Ratings from Surveys (Inspections):
Ratings from Quality Measures:
Ratings from Staffing Data:
Overall Rating:

News Archive

Preventing spread of infectious diseases is everyone's responsibility – and everyone's job

According to a report published today, we must all share responsibility for preventing the spread of diseases such as swine flu, SARS, avian influenza, diarrhoeal and skin diseases, and even the common cold.

Research leads to new potential treatment for Hereditary Hemorrhagic Telangiectasia

The work of researchers Francesc Viñals and Mariona Graupera at the Bellvitge Biomedical Research Institute - Catalan Institute of Oncology - University of Barcelona, together with Dr. Antoni Riera-Mestre, has led to a new potential treatment for Hereditary Hemorrhagic Telangiectasia or Rendu-Osler Syndrome, a rare disease that affects blood vessels and had no described treatment.

Medgen completes acquisition of Alternaturals

Medgen, Inc. today announced that it has completed the acquisition of Alternaturals, the operating subsidiary of Alternaturals, Inc., and a popular alternative healthcare and natural remedies company. The acquisition was made in an effort to increase the company's consumer reach and revenue base, and could be the most exciting event in several years, positioning the company to take some major steps forward.

Quark Pharmaceuticals commences dosing in clinical study of QPI-1007 for NAION

Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, announced today the dosing of the first patient in a Phase I study of the investigational neuroprotective agent, QPI-1007.

Read more Medical News

› Verified 4 days ago

Complaints, Fines and Penalties:

Number of Facility Reported Incidents0
Number of Substantiated Complaints0
Number of Fines1
Total Amount of Fines in Dollars$22172
Number of Payment Denials0
Total Number of Penalties1

Patients' Stay Experience:

The resident survey data of Oakview Terrace is compared against the national average with the color code indicators: Better than National Average Worse than National Average

Experience MeasureProviderNational Avg.
Percentage of long-stay residents whose need for help with daily activities has increased20.6314.46
Percentage of long-stay residents who lose too much weight1.85.51
Percentage of low risk long-stay residents who lose control of their bowels or bladder32.8948.41
Percentage of long-stay residents with a catheter inserted and left in their bladder01.79
Percentage of long-stay residents with a urinary tract infection02.65
Percentage of long-stay residents who have depressive symptoms6.065.05
Percentage of long-stay residents who were physically restrained00.23
Percentage of long-stay residents experiencing one or more falls with major injury9.713.36
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine99.4393.87
Percentage of long-stay residents who received an antipsychotic medication22.2914.2
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine85.1983.88